Goldman Sachs Group »

Edgewise Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.6M 882k 10.94
2023-09-30 $5.4M 948k 5.73
2023-06-30 $14M 1.8M 7.75
2023-03-31 $5.0M 754k 6.67
2022-12-31 $9.5M 1.1M 8.94
2022-06-30 $1.2M 146k 7.96
2022-03-31 $1.3M 132k 9.70
2021-12-31 $619k 41k 15.28
2021-03-31 $2.1M 65k 32.50